AI-generated summary
The authors studied low-level laser therapy, a form of photobiomodulation, in 40 children and adolescents aged 5 to 17 with autism spectrum disorder. Participants who received eight 5-minute treatments over four weeks showed a larger reduction in the Aberrant Behavior Checklist irritability score than placebo participants, which the authors report as statistically significant. They concluded the therapy could be an effective tool for reducing irritability.
- Participants
- 40
- Who or what was studied
- Children and adolescents aged 5 to 17 years with autism spectrum disorder and irritability
- Limits stated in the abstract
- The abstract does not report the wavelength used, and the study's design, blinding and sample size per group are not described in enough detail to judge the reliability of the findings.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Autism, Photobiomodulation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.